These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 208981)

  • 1. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses.
    Lipton HL
    Infect Immun; 1978 Jun; 20(3):869-72. PubMed ID: 208981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
    Lipton HL
    J Gen Virol; 1980 Jan; 46(1):169-77. PubMed ID: 6243340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
    Fujinami RS; Rosenthal A; Lampert PW; Zurbriggen A; Yamada M
    J Virol; 1989 May; 63(5):2081-7. PubMed ID: 2539504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Dec; 56(3):887-95. PubMed ID: 2415718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.
    Zurbriggen A; Fujinami RS
    J Virol; 1989 Apr; 63(4):1505-13. PubMed ID: 2538641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts.
    Tangy F; McAllister A; Brahic M
    J Virol; 1989 Mar; 63(3):1101-6. PubMed ID: 2536823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.
    Roos RP; Stein S; Routbort M; Senkowski A; Bodwell T; Wollmann R
    J Virol; 1989 Oct; 63(10):4469-73. PubMed ID: 2476574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
    Zurbriggen A; Fujinami RS
    J Virol; 1988 Oct; 62(10):3589-96. PubMed ID: 2843661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variants are not selected during persistent infection with Theiler's virus.
    Leibowitz JL; Rodriguez M
    Infect Immun; 1983 Jul; 41(1):440-2. PubMed ID: 6190757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theiler's murine encephalomyelitis virus--characterization of newly isolated viruses from Japanese mouse colonies.
    Miyata H; Sato H
    Jikken Dobutsu; 1990 Oct; 39(4):539-48. PubMed ID: 2242766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.
    Lipton HL
    Infect Immun; 1975 May; 11(5):1147-55. PubMed ID: 164412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses.
    Ohara Y; Senkowski A; Fu JL; Klaman L; Goodall J; Toth M; Roos RP
    J Virol; 1988 Sep; 62(9):3527-9. PubMed ID: 2457118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.
    Clatch RJ; Pevear DC; Rozhon E; Roos RP; Miller SD; Lipton HL
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3191-6. PubMed ID: 2826657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.
    Clatch RJ; Lipton HL; Miller SD
    Microb Pathog; 1987 Nov; 3(5):327-37. PubMed ID: 2849024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine specificity of T-cell-mediated immune responses of susceptible and resistant strains in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Miller SD; Clatch RJ; Lipton HL
    Ann N Y Acad Sci; 1988; 540():674-7. PubMed ID: 2849914
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptors for Theiler's murine encephalomyelitis virus: characterization by using rabbit antiviral antiserum.
    Rubio N; Cuesta A
    J Virol; 1988 Nov; 62(11):4303-6. PubMed ID: 2845143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures.
    Fujinami RS; Zurbriggen A; Powell HC
    J Neuroimmunol; 1988 Nov; 20(1):25-32. PubMed ID: 2460501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Rodriguez M; Oleszak E; Leibowitz J
    Crit Rev Immunol; 1987; 7(4):325-65. PubMed ID: 2827957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in the immune responses to Theiler's murine encephalomyelitis virus after neonatal treatment with anti-T-cell receptor antibody.
    Crane M; Miller S; Lipton H; Kim B
    Ann N Y Acad Sci; 1988; 540():669-71. PubMed ID: 2849912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.